7. November 2009 02:15
The Leukemia & Lymphoma Society (LLS) will again be participating in Gap Inc.'s Give & Get program, which in its first two campaigns this past spring and summer, garnered more than $1 million to support LLS's blood cancer research funding and patient education and support services.
[More]
7. November 2009 02:00
Registration is now open for the Society of Interventional Radiology's "Image-guided Interventional Oncology (IO) Therapies" Webinar, which will provide the latest updates on percutaneous and transcatheter treatment of liver tumors, kidney tumor ablation and lung tumor ablation.
[More]
590192c7-ed19-4c74-a0b9-4ce3a59505fd|0|.0
Posted in: Medical Procedure News | Medical Condition News
Tags: Adjuvant Therapy, Angioplasty, Cancer, Catheter, Colorectal Cancer, Cryotherapy, Education, Genetics, Hospital, Oncology, Peripheral Arterial Disease, Prostate Cancer, Radiofrequency Ablation, Radiology, Stent
7. November 2009 01:38
Depression and other emotional symptoms in survivors of torture and other traumatic experiences may be exacerbated by the effects of head injuries, according to a study from the Harvard Program in Refugee Trauma (HPRT), based in the Massachusetts General Hospital (MGH) Department of Psychiatry.
[More]
89e6dc89-8676-46b4-b2fe-9e120ba9a47a|0|.0
Posted in: Medical Condition News
Tags: Anxiety, Brain, Cancer, Cortex, Depression, Education, Genetics, Head Injury, Hospital, Mental Health, Psychiatry, Stress, Trauma
7. November 2009 01:36
"Pancreatic cancer is a rare and perplexing disease, yet it is the fourth leading cause of death by cancer in the United States. This year, more than 42,000 Americans will be diagnosed with the disease and more than 35,000 will die from it. That number is far too high.
[More]
7. November 2009 01:28
A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented by researchers at Thomas Jefferson University Hospital at the 51st ASTRO Annual Meeting.
[More]
7. November 2009 01:25
With 125 million Americans challenged by at least one chronic illness and 22% of that number facing life with two or more chronic illnesses, early, smart estate and financial planning can make the difference between maximizing control over your life or falling victim to its exigencies.
[More]
7. November 2009 01:23
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies with a stake in the market for rheumatology therapies, including rheumatoid arthritis (RA) and lupus.
[More]
7. November 2009 00:54
Research and Markets (http://www.researchandmarkets.com/research/c02179/the_2010_report_on) has announced the addition of the "The 2010 Report on Anti-Obesity Drugs: World Market Segmentation by City" report to their offering.
[More]
7. November 2009 00:42
A compound already used to treat pneumonia could become a new therapy for an inherited muscular wasting disease, according to researchers at the University of Oregon and the University of Rochester School of Medicine and Dentistry in New York.
[More]
7. November 2009 00:36
Halozyme Therapeutics, Inc. today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of lispro alone.
[More]
7. November 2009 00:33
A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms - and improved vision - following treatment with the drug rituximab. Inflammation around their eyes and damage to the optic nerve were significantly reduced. The same patients had not previously responded to steroids, a common treatment for Graves' eye disease.
[More]
7. November 2009 00:15
Researchers at St. Michael's Hospital working in conjunction with EMS services, paramedics and fire services across Ontario found that a bystander who attempts cardiopulmonary resuscitation (CPR) can quadruple the survival rate to over 50 per cent. But Dr. Laurie Morrison and the research team at Rescu (www.rescu.ca) have found only 30 per cent of bystanders in Toronto are willing to help, one of the lowest rates of bystanders helping others in the developed world.
[More]
7. November 2009 00:14
Among eligible Medicare beneficiaries, increased use of carotid arterial stenting (CAS) procedures to treat carotid stenosis-the narrowing of the carotid artery-is associated with higher rates of mortality and adverse clinical outcomes, including heart attack and stroke, according to researchers from the University of Pennsylvania School of Medicine.
[More]
7. November 2009 00:13
Mouth cancer (also called oral cancer) is a malignant growth which can occur in any part of the mouth including the lips and tongue. In the UK, the numbers of new cases have risen by over 41 per cent over the last ten years(1).
[More]
7. November 2009 00:12
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced that the company has acquired from Gilead Sciences, Inc. the worldwide license, including related regulatory filings and intellectual properties, to Gilead’s investigational molecule, GS 9191, for topical use. GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death.
[More] 
Subscribe